142 related articles for article (PubMed ID: 31116609)
21. Economic evaluation of everolimus versus sorafenib for the treatment of metastatic renal cell carcinoma after failure of first-line sunitinib.
Casciano R; Chulikavit M; Di Lorenzo G; Liu Z; Baladi JF; Wang X; Robertson J; Garrison L
Value Health; 2011; 14(6):846-51. PubMed ID: 21914504
[TBL] [Abstract][Full Text] [Related]
22. Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model.
Jones-Hughes T; Snowsill T; Haasova M; Coelho H; Crathorne L; Cooper C; Mujica-Mota R; Peters J; Varley-Campbell J; Huxley N; Moore J; Allwood M; Lowe J; Hyde C; Hoyle M; Bond M; Anderson R
Health Technol Assess; 2016 Aug; 20(62):1-594. PubMed ID: 27578428
[TBL] [Abstract][Full Text] [Related]
23. A Decision Analysis for Rectal-Sparing Familial Adenomatous Polyposis: Total Colectomy With Ileorectal Anastomosis Versus Proctocolectomy With IPAA.
Melnitchouk N; Saadat LV; Bleday R; Goldberg JE
Dis Colon Rectum; 2019 Jan; 62(1):27-32. PubMed ID: 30394986
[TBL] [Abstract][Full Text] [Related]
24. A Bayesian model averaging approach with non-informative priors for cost-effectiveness analyses.
Conigliani C
Stat Med; 2010 Jul; 29(16):1696-709. PubMed ID: 20572119
[TBL] [Abstract][Full Text] [Related]
25. [Decision analysis in radiology using Markov models].
Golder W
Rofo; 2000 Jan; 172(1):80-5. PubMed ID: 10719468
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the flexible parametric survival model and Cox model in estimating Markov transition probabilities using real-world data.
Du X; Li M; Zhu P; Wang J; Hou L; Li J; Meng H; Zhou M; Zhu C
PLoS One; 2018; 13(8):e0200807. PubMed ID: 30133454
[TBL] [Abstract][Full Text] [Related]
27. [Comparison of medical and economic benefits of antipsychotics in the treatment of schizophrenia in France].
Druais S; Doutriaux A; Cognet M; Godet A; Lançon C; Levy P; Samalin L; Guillon P
Encephale; 2017 Aug; 43(4):311-320. PubMed ID: 27623123
[TBL] [Abstract][Full Text] [Related]
28. Characterizing Heterogeneity Bias in Cohort-Based Models.
Elbasha EH; Chhatwal J
Pharmacoeconomics; 2015 Aug; 33(8):857-65. PubMed ID: 25851486
[TBL] [Abstract][Full Text] [Related]
29. [Probabilistic cost-effectiveness analysis of the treatment of sleep apnea].
Mar J; Gutiérrez-Moreno S; Chilcott J
Gac Sanit; 2006; 20(1):47-53. PubMed ID: 16539993
[TBL] [Abstract][Full Text] [Related]
30. A comparison of published time invariant Markov models with Partitioned Survival models for cost effectiveness estimation; three case studies of treatments for glioblastoma multiforme.
Connock M; Auguste P; Armoiry X
Eur J Health Econ; 2021 Feb; 22(1):89-100. PubMed ID: 33130929
[TBL] [Abstract][Full Text] [Related]
31. Illustrating economic evaluation of diagnostic technologies: comparing Helicobacter pylori screening strategies in prevention of gastric cancer in Canada.
Xie F; O'Reilly D; Ferrusi IL; Blackhouse G; Bowen JM; Tarride JE; Goeree R
J Am Coll Radiol; 2009 May; 6(5):317-23. PubMed ID: 19394572
[TBL] [Abstract][Full Text] [Related]
32. Cost-Effectiveness of Total Hip Arthroplasty Versus Nonoperative Management in Normal, Overweight, Obese, Severely Obese, Morbidly Obese, and Super Obese Patients: A Markov Model.
Ponnusamy KE; Vasarhelyi EM; McCalden RW; Somerville LE; Marsh JD
J Arthroplasty; 2018 Dec; 33(12):3629-3636. PubMed ID: 30266324
[TBL] [Abstract][Full Text] [Related]
33. Ticagrelor for Secondary Prevention of Atherothrombotic Events After Myocardial Infarction: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Pouwels XGLV; Wolff R; Ramaekers BLT; Van Giessen A; Lang S; Ryder S; Worthy G; Duffy S; Armstrong N; Kleijnen J; Joore MA
Pharmacoeconomics; 2018 May; 36(5):533-543. PubMed ID: 29344794
[TBL] [Abstract][Full Text] [Related]
34. Probabilistic Sensitivity Analysis in Cost-Effectiveness Models: Determining Model Convergence in Cohort Models.
Hatswell AJ; Bullement A; Briggs A; Paulden M; Stevenson MD
Pharmacoeconomics; 2018 Dec; 36(12):1421-1426. PubMed ID: 30051268
[TBL] [Abstract][Full Text] [Related]
35. Long-term cost-effectiveness of home versus clinic-based management of chronic heart failure: the WHICH? study.
Maru S; Byrnes JM; Carrington MJ; Stewart S; Scuffham PA
J Med Econ; 2017 Apr; 20(4):318-327. PubMed ID: 27841726
[TBL] [Abstract][Full Text] [Related]
36. Economic Evaluation of Interventions to Address Opioid Misuse: A Systematic Review of Methods Used in Simulation Modeling Studies.
Barbosa C; Dowd WN; Zarkin G
Value Health; 2020 Aug; 23(8):1096-1108. PubMed ID: 32828223
[TBL] [Abstract][Full Text] [Related]
37. Cost-Utility Analysis of Telemonitoring Interventions for Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany.
Hofer F; Achelrod D; Stargardt T
Appl Health Econ Health Policy; 2016 Dec; 14(6):691-701. PubMed ID: 27475635
[TBL] [Abstract][Full Text] [Related]
38. Cost effectiveness of prostacyclins in pulmonary arterial hypertension.
Roman A; Barberà JA; Escribano P; Sala ML; Febrer L; Oyagüez I; Sabater E; Casado MA
Appl Health Econ Health Policy; 2012 May; 10(3):175-88. PubMed ID: 22452448
[TBL] [Abstract][Full Text] [Related]
39. The role of value-of-information analysis in a health care research priority setting: a theoretical case study.
Corro Ramos I; Rutten-van Mölken MP; Al MJ
Med Decis Making; 2013 May; 33(4):472-89. PubMed ID: 23275451
[TBL] [Abstract][Full Text] [Related]
40. [Cost-effectiveness analysis of maintenance therapy with rituximab in patients with follicular lymphoma responding to induction therapy at the first line].
Castro Gómez AJ; López-Guillermo A; Rueda Domínguez A; Salar A; Varela Moreno C; Rubio-Terrés C
Rev Esp Salud Publica; 2012; 86(2):163-76. PubMed ID: 22991059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
